tirapazamine
Term · Oncology and biomedicine · MLC-T-ONC-008720
A substance that has been studied in the treatment of some types of cancer. It may cause damage to the DNA in cells that have a low level of oxygen, including cancer cells. This may make the cells easier to kill with radiation therapy and chemotherapy. Tirapazamine is a type of radiosensitizing agent and a type of chemosensitizing agent.
A benzotriazine di-N-oxide with potential antineoplastic activity. Tirapazamine is selectively activated by multiple reductases to form free radicals in hypoxic cells, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. This agent also sensitizes hypoxic cells to ionizing radiation and inhibits the repair of radiation-induced DNA strand breaks via inhibition of topoisomerase II.
| Identifier | MLC-T-ONC-008720 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-008720",
"term": "tirapazamine",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that has been studied in the treatment of some types of cancer. It may cause damage to the DNA in cells that have a low level of oxygen, including cancer cells. This may make the cells easier to kill with radiation therapy and chemotherapy. Tirapazamine is a type of radiosensitizing agent and a type of chemosensitizing agent.",
"A benzotriazine di-N-oxide with potential antineoplastic activity. Tirapazamine is selectively activated by multiple reductases to form free radicals in hypoxic cells, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. This agent also sensitizes hypoxic cells to ionizing radiation and inhibits the repair of radiation-induced DNA strand breaks via inhibition of topoisomerase II."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tirapazamine/"
}
Record 16,393 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.